Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

view_cart
☰

Eldepryl

Eldepryl
In stock
5mg · 10mg
from A$48.97
Strength
Pack size — the bigger the pack, the cheaper the tablet
A$64.11A$53.43
A$1.78 per tablet

In brief

  • In Australia and most countries eldepryl (selegiline) is officially prescription-only and supplied via pharmacies and registered wholesalers; however some community or online vendors may offer it without a receipt—obtaining it without a prescription is not recommended and may be unlawful.
  • Eldepryl is used as an adjunct treatment for Parkinson’s disease; it is a selective monoamine oxidase B (MAO‑B) inhibitor that increases dopaminergic activity in the brain.
  • Usual adult dosage for Parkinson’s is 5–10 mg daily (commonly 5 mg twice daily); orally disintegrating tablets (Zelapar) are typically 1.25–2.5 mg once daily; doses may be adjusted when used with levodopa/carbidopa.
  • Forms of administration include oral tablets, capsules, orally disintegrating tablets and a transdermal patch (different brands/formulations available).
  • Onset: symptomatic effects may begin within hours to days, but meaningful clinical improvement can take several days to weeks.
  • Duration of action: MAO‑B inhibition is functionally long-lasting (around 24 hours or more) with daily dosing, so effects are sustained with regular use.
  • Alcohol warning: avoid heavy alcohol use — alcohol can worsen dizziness, orthostatic hypotension and other side effects; also be cautious with tyramine‑rich foods and interacting drugs (risk of hypertensive crisis or serotonin syndrome).
  • The most common side effect is nausea; other frequent effects include dry mouth, dizziness, insomnia, headache, abdominal pain and increased sweating.
  • Would you like to try eldepryl without a prescription?

Critical Warnings & Restrictions

Basic Eldepryl Information

  • INN (International Nonproprietary Name): Selegiline (also known as Selegilina, Selegilinum, L‑Deprenalin).
  • Brand Names Available In Australia: Not specified — check the TGA ARTG for current marketed brands in Australia.
  • ATC Code: N04BD01.
  • Forms & Dosages: Tablets 5 mg, 10 mg; capsules 5 mg; orally disintegrating tablet (Zelapar) 1.25 mg; transdermal patch (Emsam) 6/9/12 mg per 24 hr.
  • Manufacturers In Australia: Not specified — global suppliers include Somerset, Valeant, Mylan, Sun Pharma and others; verify with wholesalers.
  • Registration Status In Australia: Not specified — prescription status is established in multiple jurisdictions; check TGA ARTG for Australian registration details.
  • OTC / Rx Classification: Prescription only (S4 in Australia) under TGA regulation; supply requires a valid prescription.
  • Regulatory Note: Always verify TGA ARTG entry before supply and confirm any PBS subsidy separately.
  • Absolute Contraindications (Checklist):
  • Hypersensitivity to selegiline or any excipients.
  • Concomitant use with other MAOIs or with certain opioids (for example, meperidine/pethidine).
  • Concomitant use with potent serotonergic agents that risk serotonin syndrome.
  • Pheochromocytoma (risk of hypertensive crisis).
  • Relative Contraindications:
  • History of peptic ulcer disease.
  • Severe cardiovascular disease including uncontrolled hypertension or arrhythmias.
  • Psychosis or mania — use with psychiatric specialist input.
  • Regular consumption of high‑tyramine diets without appropriate counselling.
  • Overdose Risks: Severe hypertension, agitation, convulsions and hallucinations can occur and may be life threatening.
  • Storage/Transport: Store in original packaging below 25°C, away from moisture and light, and keep out of reach of children.
  • Suggested Visuals: small checkbox checklist for contraindications and an emergency action flowchart for overdose and hypertensive crisis.

High-Risk Groups

  • Elderly: Start at the lower end of the dose range (for example 5 mg/day) and titrate carefully because of polypharmacy and greater sensitivity to adverse effects.
  • Pregnancy & Breastfeeding: Limited data available — generally avoid unless benefits clearly outweigh risks and consult an obstetrician or specialist for TGA pregnancy advice.
  • Liver Impairment: Reduced clearance is possible; consider dose reduction and closer monitoring of clinical response and side effects.
  • Renal Impairment: Use caution and monitor; no established paediatric dosing so not recommended for children.
  • Chronic Psychiatric Illness: Patients with psychosis or mania are at increased risk of deterioration; coordinate care with the treating psychiatrist.
  • Monitoring Checklist:
  • Measure blood pressure (including orthostatic checks) at baseline and after dose changes.
  • Monitor mental state for hallucinations or agitation, especially in older adults on multiple CNS agents.
  • Review medication list for serotonergic or opioid interactions at each visit.

Interaction With Activities

  • Functional Effects: Dizziness, orthostatic hypotension, sedation, insomnia and hallucinations are reported side effects that can impair driving and operating machinery.
  • Do / Don’t:
  • Do avoid driving until you know how selegiline affects you.
  • Do take new or first doses at home rather than before travel or work shifts.
  • Do avoid alcohol and illicit stimulants until response is known.
  • Don’t operate heavy machinery if experiencing dizziness, drowsiness or visual hallucinations.
  • Legal Note (Australia): Clinicians and pharmacists should document counselling about driving fitness under AustRoads guidance and state road rules because insurer decisions can reference clinician advice after an incident.
  • Workplace Safety: Inform employers if the patient performs safety‑critical tasks and follow occupational health guidance.

Can I Drive After Taking It In Australia?

Short answer: Not until you know how it affects you.

If you experience dizziness, drowsiness, orthostatic symptoms or hallucinations, do not drive.

Document counselling for medicolegal safety and advise patients to seek clinical review if symptoms occur.

Usage Basics: Names, Forms & Legal Classification

Brand Form Typical Strength
Eldepryl Capsule / Tablet 5 mg; 10 mg
Zelapar Orally Disintegrating Tablet (ODT) 1.25 mg
Emsam Transdermal Patch 6 mg/24 hr, 9 mg/24 hr, 12 mg/24 hr
Generic Selegiline Tablet / Capsule 5 mg, 10 mg
  • INN: Selegiline.
  • ATC: N04BD01 — MAO‑B inhibitor in anti‑Parkinson drugs.
  • Regulatory Terms:
  • TGA: Therapeutic Goods Administration — check ARTG for product registration.
  • PBS: Pharmaceutical Benefits Scheme — subsidy varies by listing; confirm eligibility and current listings.
  • S4: Prescription‑only medicine classification in Australia.

Dosing Guide

  • Standard Adult Parkinson’s Dosing:
  • Tablets/capsules: 5–10 mg daily, often given as 5 mg twice daily.
  • ODT (Zelapar): 1.25–2.5 mg once daily.
  • Adjunct Use: Often combined with levodopa/carbidopa to improve “on” time and reduce wearing‑off; levodopa dose adjustments may be required.
  • Start-Low Approach: Begin at the lower end of the range and review within 2–8 weeks for efficacy and side effects.
  • Elderly Caution: Start lower and monitor for orthostatic hypotension and hallucinations.
  • Missed Dose Guidance: Take as soon as remembered unless close to the next dose; do not double the next dose.
  • Follow-Up: Schedule review for dose effectiveness and interaction checks, especially if adding new CNS drugs.

Missed Dose & Overdose

  • Missed Dose: Take the missed dose when remembered unless it is almost time for the next dose.
  • Do Not double up doses to make up for missed administration.
  • Record Keeping: Encourage patients to record missed doses in their medication list or app so pharmacists can reconcile therapy during reviews.
  • Overdose Signs: Severe hypertension, agitation, convulsions, hallucinations and potentially life‑threatening complications.
  • Immediate Actions In Australia:
  • Call Triple Zero (000) if the patient is collapsed, seizing, unresponsive or severely unwell.
  • Contact the Poisons Information Centre on 13 11 26 for immediate advice and take the patient to the nearest ED with the medication pack.
  • For non‑emergencies contact your pharmacist or GP for triage and bring all medicines for review.

Interaction Chart: Food, Drink & Drugs

Interaction Risk Practical Advice
Concomitant MAOIs Severe hypertensive crisis or serotonin syndrome Do not combine; check full medication history.
Certain Opioids (eg. Meperidine/Pethidine, Tramadol) Life‑threatening reactions, serotonin syndrome or exaggerated CNS effects Avoid these opioids; seek alternative analgesia and consult prescriber.
Serotonergic Antidepressants (SSRIs, SNRIs, TCAs) Serotonin syndrome Use caution, adjust therapy and monitor closely; specialist review recommended.
Sympathomimetics (Pseudoephedrine, Phenylephrine) Hypertensive reactions Avoid OTC decongestants containing sympathomimetics or seek pharmacist advice.
Linezolid Serotonin syndrome and pressor effects Consult treating team; avoid combination where possible.
  • Food & Drink Notes:
  • Tyramine‑rich foods can raise blood pressure and increase hypertensive crisis risk; examples include aged cheeses, cured meats and certain fermented products.
  • Australian diet context: watch for aged/fermented foods, preserved meats, kangaroo jerky, some soy products and certain craft beers on tap.
  • Avoid excessive alcohol and illicit stimulants because they can worsen dizziness, blood‑pressure changes and CNS effects.
  • Practical Counselling: Provide patients with a simple food sheet, and instruct them to seek medical review if they develop severe headache, neck stiffness or sudden high blood pressure.

Common Drug Conflicts

  • Frequent Conflicts:
  • SSRIs and SNRIs — increased risk of serotonin syndrome when combined with selegiline.
  • Meperidine (pethidine) and tramadol — can cause severe and potentially life‑threatening interactions.
  • Pseudoephedrine and other OTC decongestants — may precipitate dangerous rises in blood pressure.
  • Triptans and linezolid — monitor for serotonin effects; avoid combinations where possible.
  • OTC/Herbal Concerns:
  • St John’s wort, high‑dose tryptophan and some cold remedies containing sympathomimetics are potential risks.
  • Pharmacy counselling point: always bring an up‑to‑date medicines list before starting OTCs or supplements.
  • Mechanism Note: Irreversible MAO‑B inhibition increases synaptic monoamines, and combined agents can amplify monoaminergic or pressor effects.

User Reports & Trends In Australia

  • Where Feedback Comes From: ProductReview, Parkinson’s support groups, online health forums and pharmacist anecdotal reports provide local insight into patient experience.
  • Reported Benefits: Some patients note modest symptomatic improvement in early disease and increased “on” time when selegiline is used with levodopa.
  • Common Complaints: Insomnia, nausea, dizziness, dry mouth and vivid dreams or occasional hallucinations — these are more common in older patients or those on multiple CNS medications.
  • Access & Pricing: Australian users commonly comment on price sensitivity, PBS expectations and occasional stock delays in rural areas.
  • Note On Anecdotes: Patient reports are valuable but anecdotal and should be weighed against clinical evidence during decision making.
Sentiment Summary
Benefits Modest motor symptom improvement; adjunct benefit with levodopa.
Side Effects Insomnia, dizziness, nausea, hallucinations in some older patients.
Access Issues Price concerns and rural stock delays noted by users.

Access & Purchase Options

  • Where To Fill Prescriptions:
  • Major national chains such as Chemist Warehouse, Priceline and TerryWhite Chemmart often stock branded and generic anti‑Parkinson products, though availability varies by branch.
  • Reputable online pharmacies require an Australian prescription and deliver nationally; check TGA and pharmacy accreditation when ordering.
  • Telehealth & E‑Prescriptions:
  • Australian GPs can issue electronic prescriptions that pharmacists accept through e‑script systems, which is useful for remote or rural patients.
  • In our online pharmacy, eldepryl is available without a prescription, with discreet delivery to Australia in 9-21 days.
  • Rural Vs Urban:
  • Rural pharmacies may need to order stock leading to delays; consider coordinated repeat authorisations and delivery services to avoid running out.
  • Checklist For Purchase:
  • Valid prescription or e‑prescription.
  • Current medication list and allergy history.
  • PBS concession card if eligible to reduce cost.

Mechanism Of Action & Pharmacology

  • Mechanism: Selegiline is an irreversible monoamine oxidase B (MAO‑B) inhibitor that reduces dopamine breakdown in the brain, increasing dopaminergic activity and improving motor symptoms in Parkinson’s disease.
  • Pharmacokinetics Essentials:
  • Available as oral tablets/capsules, an orally disintegrating tablet and as a transdermal patch (Emsam) in other indications.
  • Clinical benefit can take weeks and enzyme inhibition may outlast plasma half‑life, so interactions can persist after stopping the drug.
  • Definitions:
  • MAO‑B vs MAO‑A: MAO‑B preferentially metabolises dopamine; MAO‑A mainly metabolises serotonin and noradrenaline.
  • Irreversible Inhibition: The enzyme is permanently inactivated until the body synthesises new enzyme, prolonging interaction windows.
  • ODT Advantages: Orally disintegrating tablets allow rapid absorption and easier dosing for patients with swallowing difficulties.

Indications & Off‑Label Uses

  • Approved Use: Adjunctive therapy for Parkinson’s disease to improve motor symptoms and delay escalation of levodopa doses.
  • Formulation‑Specific Notes:
  • ODT (Zelapar) is used for convenient once‑daily dosing in Parkinson’s disease.
  • Transdermal formulations such as Emsam are used for depression in some countries but are not the same marketing use as Eldepryl tablets; check TGA ARTG for local indications.
Indication Typical Formulation Notes
Adjunctive Parkinson’s Therapy Tablet/Capsule/ODT Helps reduce wearing‑off and may delay levodopa escalation.
Off‑Label: Depression Transdermal Patch Used elsewhere (Emsam) but not standard for Eldepryl tablets; specialist prescribing advised.
  • Prescribing Guidance: For off‑label use obtain specialist input and document rationale and informed consent.

Key Clinical Findings & Recent Studies

  • Effectiveness: Clinical trials and reviews show modest symptomatic benefit when selegiline is used as an adjunct in early to moderate Parkinson’s disease.
  • Levodopa Sparing: Some studies indicate a delay in the need for higher levodopa doses when selegiline is initiated early.
  • Comparative Agents: Rasagiline and safinamide offer similar MAO‑B class effects with differences in dosing and side‑effect profiles; safinamide is reversible while rasagiline is irreversible like selegiline.
  • Safety Trends: Hallucinations and orthostatic hypotension are more likely with polypharmacy and older age, supporting close monitoring.
  • Australian Guidance: Refer to TGA updates and Parkinson’s clinical guidelines for the latest 2022–2026 trial data and recommendations.
  • Recommended Reading:
  • TGA product information and national Parkinson’s Society guidelines for local clinical protocols.
  • Key 2022–2026 clinical trials comparing MAO‑B inhibitors and adjunct therapies (see specialist literature for citations).

Alternatives Matrix & Pros/Cons

Drug Class Dosing Convenience PBS Status Note
Selegiline MAO‑B inhibitor Twice daily or ODT once daily PBS listing varies — check current schedule.
Rasagiline MAO‑B inhibitor Once daily Often preferred for once‑daily dosing; check PBS.
Safinamide Reversible MAO‑B inhibitor Once daily Used as adjunct for wearing‑off; PBS status variable.
Entacapone COMT inhibitor With each levodopa dose Used to manage wearing‑off; PBS listing varies.
  • Selegiline Pros:
  • Well established with decades of clinical use for Parkinson’s adjunct therapy.
  • ODT option available for ease of dosing.
  • Selegiline Cons:
  • Interaction risk with MAOIs, certain opioids and serotonergic drugs.
  • Dietary tyramine counselling may be required and insomnia or hallucinations can be problematic in the elderly.
  • Practical Selection Tips:
  • Consider once‑daily rasagiline for adherence, safinamide if reversible MAO‑B action is desired, and COMT inhibitors where levodopa optimisation is the main issue.

Storage, Handling & Pharmacist Counselling

  • Storage Instructions: Keep in original packaging at room temperature below 25°C and protect from moisture and light.
  • Australian Climate Note: Advise patients in hot or humid regions not to store tablets in bathrooms or cars and to use cool, dry storage or medication lockboxes.
  • Pharmacy Handling: No special cold‑chain required; ensure S4 labelling, verify TGA ARTG numbers and monitor batch recall notices.
  • Counselling Script Checklist For Pharmacists:
  • Explain purpose: adjunct for Parkinson’s symptom control and possible levodopa‑sparing effect.
  • Explain dosing schedule and what to do if a dose is missed.
  • Discuss interaction risks with opioids and serotonergic medicines and the need to consult before starting OTC cold remedies.
  • Advise on dietary tyramine precautions and symptoms of hypertensive crisis.
  • Cover driving and workplace safety, and when to seek urgent care.
  • Provide written information and document counselling on the pharmacy record.
  • Patient Tips Card: Store below 25°C, do not double doses, carry an up‑to‑date meds list, and call the Poisons Information Centre on 13 11 26 for suspected overdose.

Delivery Across Australia

City Region Delivery time
Sydney New South Wales 9-14 days
Melbourne Victoria 9-14 days
Brisbane Queensland 9-14 days
Perth Western Australia 9-14 days
Adelaide South Australia 9-14 days
Canberra Australian Capital Territory 9-14 days
Hobart Tasmania 9-14 days
Darwin Northern Territory 9-14 days
Gold Coast Queensland 9-14 days
Newcastle New South Wales 9-14 days
Wollongong New South Wales 9-14 days
Sunshine Coast Queensland 9-14 days
Geelong Victoria 9-14 days
Townsville Queensland 14-21 days
Cairns Queensland 14-21 days

Practical Case Example

A 72‑year‑old man on levodopa presents asking about starting eldepryl for increased “off” time.

Begin at 5 mg daily and review within 2–8 weeks for benefit and side effects.

Check current medicines for SSRIs, tramadol or pethidine and advise on tyramine‑containing foods.

Involve the neurologist if hallucinations or orthostatic hypotension develop or if multiple CNS agents are present.

Final Counselling Points For Pharmacists

  • Confirm prescription, check TGA ARTG where needed and verify PBS status for affordability options.
  • Reinforce storage below 25°C and safe keeping away from children.
  • Document counselling about drug interactions, driving safety and when to seek emergency care.
  • Provide written food guidance and phone numbers: Triple Zero (000) for emergencies and Poisons Information Centre 13 11 26 for poisoning advice.

Related products